# Evaluation of Gd-EOB-DTPA MRI for Detection and Characterization of Liver Nodules in Cirrhotic Patients Undergoing Liver Transplantation and Potential Impact on Transplant Eligibility

> **NCT03342677** · NA · UNKNOWN · sponsor: **University Health Network, Toronto** · enrollment: 80 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DIAGNOSTIC_TEST:** Primovist MRI

## Key facts

- **NCT ID:** NCT03342677
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-11-07
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2021-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03342677

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03342677, "Evaluation of Gd-EOB-DTPA MRI for Detection and Characterization of Liver Nodules in Cirrhotic Patients Undergoing Liver Transplantation and Potential Impact on Transplant Eligibility". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03342677. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*